TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06610539: PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Sponsor: Endomagnetics Ltd. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 184 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT06610539 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06610539 Rescue Dossier →